ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,682.40
0.70%
S&P ASX All Technology
3,019.20
0.10%
Brent Oil
82.915
-0.25%
US Dollar vs AUD
1.50884
-0.27%
Bitcoin
63,191.89
-1.26%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Quoin Pharmaceuticals Ltd (QNRX)

  7. Quoin Pharmaceuticals Ltd (QNRX) News

QNRX Quoin Pharmaceuticals Ltd

0.75
-0.0263 (-3.39%)
Last Updated: 03:34:35
Delayed by 15 minutes
Share Name Share Symbol Market Stock Type
Quoin Pharmaceuticals Ltd QNRX NASDAQ Depository Receipt
  Price Change Price Change % Share Price Last Trade
Upgrade Icon
-0.0263 -3.39% 0.75 03:34:35
Open Price Low Price High Price Close Price Previous Close
0.7775 0.7352 0.80 0.7763
more quote information »

Recent News

Date Time Source Heading
03/5/202406:10GLOBEQuoin Pharmaceuticals to Announce First Quarter 2024..
14/3/202407:05GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
13/3/202422:03IHMARKETNEWSMixed Futures Amidst Quiet Economic Schedule; Oil Prices..
09/3/202408:06EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/3/202408:04EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
09/3/202408:01EDGAR2Form 8-K - Current report
08/3/202408:05GLOBEQuoin Pharmaceuticals Announces Fourth Quarter and 2023..
07/3/202409:07EDGAR2Form 424B4 - Prospectus [Rule 424(b)(4)]
07/3/202408:01EDGAR2Form 8-K - Current report
06/3/202400:00GLOBEQuoin Pharmaceuticals Announces Pricing of $6.5 Million..
05/3/202409:27EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
05/3/202400:00GLOBEQuoin Pharmaceuticals Announces FDA Clearance to Recruit..
27/2/202422:01EDGAR2Form DEF 14A - Other definitive proxy statements
15/2/202416:15EDGAR2Form EFFECT - Notice of Effectiveness
14/2/202412:11EDGAR2Form SC 13G/A - Statement of acquisition of beneficial..
14/2/202408:50EDGAR2Form S-1/A - General form for registration of securities..
14/2/202408:30EDGAR2Form PRE 14A - Other preliminary proxy statements
13/2/202409:12EDGAR2Form S-1 - General form for registration of securities under..
09/2/202400:00GLOBEQuoin Pharmaceuticals Files U.S. and International Patent..
31/1/202408:05EDGAR2Form 8-K - Current report
19/12/202309:30EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
19/12/202309:29EDGAR2Form 8-K - Current report
14/12/202300:30GLOBEQuoin Pharmaceuticals Announces FDA Clearance of Clinical..
10/11/202309:15EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
10/11/202309:11EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
10/11/202309:10EDGAR2Form 8-K - Current report
09/11/202309:46GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
08/11/202309:14EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
07/11/202308:17EDGAR2Form 8-K - Current report
03/11/202323:41GLOBEQuoin Pharmaceuticals Announces Third Quarter 2023 Financial..
02/11/202308:18EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
02/11/202307:59EDGAR2Form 8-K - Current report
31/10/202307:12EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202307:11EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202307:10EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202307:08EDGAR2Form 4 - Statement of changes in beneficial ownership of..
31/10/202307:06EDGAR2Form 4 - Statement of changes in beneficial ownership of..
25/10/202300:32GLOBEREPEAT -- Quoin Pharmaceuticals Announces Additional..
24/10/202323:28GLOBEQuoin Pharmaceuticals Announces Additional Positive Clinical..
20/10/202308:00EDGAR2Form DEFA14A - Additional definitive proxy soliciting..
15/9/202306:38EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
12/9/202320:03EDGAR2Form DEF 14A - Other definitive proxy statements
02/9/202303:38EDGAR2Form PRE 14A - Other preliminary proxy statements
04/8/202306:51EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
04/8/202304:14EDGAR2Form 10-Q - Quarterly report [Sections 13 or 15(d)]
03/8/202307:01EDGAR2Form 8-K - Current report
03/8/202306:45GLOBEQuoin Pharmaceuticals Provides Corporate Update and..
27/7/202322:00GLOBEQuoin Pharmaceuticals Announces Second Quarter 2023..
19/7/202306:43EDGAR2Form 424B3 - Prospectus [Rule 424(b)(3)]
15/7/202307:06EDGAR2Form 8-K/A - Current report: [Amend]

Your Recent History

NASDAQ
QNRX
Quoin Pharmaceuticals
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved